J. Carlet, Tous ensemble, sauvons les antibitiques Propositions du groupe de travail spécial pour la préservation des antibiotiques Available from: http://social-sante.gouv, 2015.

E. Burden and B. , Etude finalisées / Enquêtes et études / Résistance aux anti-infectieux / Maladies infectieuses / Dossiers thématiques / Accueil [Internet] Available from: http://www.invs.sante.fr/Dossiers-thematiques/Maladies-infectieuses/Resistance-aux-anti-infectieux/Enquetes-et-etudes/Etude- finalisees/Etude-Burden-BMR-estimation-du-poids-des-infections-a-bacteries-multiresistantes-en-France, 2016.

J. Carlet, C. Rambaud, and C. Pulcini, Alliance contre les bactéries multirésistantes : sauvons les antibiotiques ! Ann Fr Anesth Réanimation, pp.704-712, 2012.
DOI : 10.1016/j.annfar.2012.07.003

S. Matanovic, U. Bergman, D. Vukovic, B. Wettermark, and V. Vlahovic-palcevski, Impact of restricted amoxicillin/clavulanic acid use on Escherichia coli resistance???antibiotic DU90% profiles with bacterial resistance rates: a visual presentation, International Journal of Antimicrobial Agents, vol.36, issue.4, pp.369-73, 2010.
DOI : 10.1016/j.ijantimicag.2010.05.019

W. Van-der-starre, C. Van-nieuwkoop, S. Paltansing, J. Van-'t-wout, G. Groeneveld et al., Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection, Journal of Antimicrobial Chemotherapy, vol.66, issue.3, pp.650-656, 2011.
DOI : 10.1093/jac/dkq465

I. Willemsen, A. Groenhuijzen, D. Bogaers, A. Stuurman, P. Van-keulen et al., Appropriateness of Antimicrobial Therapy Measured by Repeated Prevalence Surveys, Antimicrobial Agents and Chemotherapy, vol.51, issue.3, pp.864-871, 2007.
DOI : 10.1128/AAC.00994-06

E. Remy, R. Favreau, N. Mariette, C. Tharasse, F. Caron et al., Évaluation des pratiques de prescription des fluoroquinolones à l'hôpital. Rev Médecine Interne, pp.875-80, 2008.
DOI : 10.1016/j.revmed.2008.02.018

B. Politis, V. Pagnon, C. Lescot, P. Faure, S. Touratier et al., Prescription des fluoroquinolones ?? l???h??pital Saint-Louis??: enqu??te avant et apr??s diffusion de recommandations et interventions du r??f??rent anti-infectieux, Pathologie Biologie, vol.58, issue.6, pp.415-424, 2010.
DOI : 10.1016/j.patbio.2008.11.004

K. Laupland, D. Church, J. Vidakovich, M. Mucenski, and J. Pitout, Community-onset extended-spectrum ??-lactamase (ESBL) producing Escherichia coli: Importance of international travel, Journal of Infection, vol.57, issue.6, pp.441-449, 2008.
DOI : 10.1016/j.jinf.2008.09.034

O. Neill, J. Vaccines, . And, . Approaches, . Reducing et al., Available from: http://amrreview .org/sites/default/files/Vaccines%20and%20alternatives_v4_LR.pdf 18. HAS. RECOMMANDATIONS PROFESSIONNELLES, Stratégie d'antibiothérapie et prévention des résistances bactériennes en établissement de santé [Internet], p.2016, 2008.

E. Society and . Cardiology, 2015 ESC Guidelines for the management of infective endocarditis, 2015.

J. Oosterheert, M. Bonten, M. Schneider, E. Buskens, J. Lammers et al., Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial, BMJ, vol.333, issue.7580, p.1193, 2006.
DOI : 10.1136/bmj.38993.560984.BE

J. Lemtiri-florek, M. Ségard, A. Descamps, M. Delvallée, M. Dubus et al., Bon usage des anti-infectieux: évolution des interventions pharmaceutiques en deux ans au Centre hospitalier de Seclin, J Pharm Clin, vol.32, issue.1, pp.31-42, 2013.

V. Gunten, . Von, J. Reymond, and J. Beney, Clinical and economic outcomes of pharmaceutical services related to antibiotic use: a literature review. Pharm World Sci, Feb, vol.229, issue.3, pp.146-63, 2007.

R. Priano, C. Baudin, R. Pitti, B. Gustin, and P. Roux, Prescriptions dâ? TM antibiotiques : intervention dâ? TM un pharmacien dans une unité de soins intensifs de chirurgie cardiaque, J Pharm Clin, vol.24, issue.4, pp.203-211, 2005.

S. Jiang, Z. Zhu, K. Ma, X. Zheng, and X. Lu, Impact of pharmacist antimicrobial dosing adjustments in septic patients on continuous renal replacement therapy in an intensive care unit, Scandinavian Journal of Infectious Diseases, vol.80, issue.12, pp.891-900, 2013.
DOI : 10.7326/0003-4819-140-10-200405180-00017

J. Finlay, L. Miller, and J. Poupard, A review of the antimicrobial activity of clavulanate, Journal of Antimicrobial Chemotherapy, vol.52, issue.1, pp.18-23, 2003.
DOI : 10.1093/jac/dkg286

E. Senneville, . Nguyen, and . Sophie, Protocole d'antibiotherapie hebergement septique clinique d'orthopedie-traumatologie chu lille

P. Poulain, Survenue d'une FIEVRE pendant la grossesse, le travail ou le post-partum, 2005.

C. Martin, Antibioprophylaxie en chirurgie et médecine interventionnelle (patients adultes) [Internet]. SFAR Available from: http://sfar.org/antibioprophylaxie-en-chirurgie-et-medecine-interventionnelle-patients-adultes, 2010.

F. Salvo, G. Polimeni, U. Moretti, A. Conforti, R. Leone et al., Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy, Journal of Antimicrobial Chemotherapy, vol.60, issue.1, pp.121-127, 2007.
DOI : 10.1093/jac/dkm111

J. F. , W. K. Hd, and H. , In-vitro activity of augmentin against clinically important gram-positive and gram-negative bacteria in comparison with other antibiotics, Zentralbl Bakteriol Mikrobiol Hyg [A], vol.256, issue.4, pp.523-553, 19841984.

S. Sandrini, M. Aldriwesh, M. Alruways, and P. Freestone, Microbial endocrinology: host-bacteria communication within the gut microbiome, Journal of Endocrinology, vol.225, issue.2, pp.21-34
DOI : 10.1530/JOE-14-0615

L. Beaugerie, A. Flahault, F. Barbut, P. Atlan, V. Lalande et al., Antibiotic-associated diarrhoea and Clostridium difficile> in the community, Alimentary Pharmacology and Therapeutics, vol.250, issue.7, pp.905-917, 2003.
DOI : 10.1016/S0140-6736(00)03592-3

S. Carl and A. , Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals, 2011.

. Bouyet, Méthodes statistiques en médecine et en biologie, 1997.

M. Mouquet, Hospitalisation de court séjour : quels motifs de recours en 2013 ? -Études et résultats -Ministère des Affaires sociales et de la Santé [Internet] Direction de la recherche, des études, de l'évaluation et des statistiques (DREES), Août, 2015.

C. Dupont, C. Masse, B. Auvert, B. Page, B. Heym et al., ??valuation des prescriptions d???amoxicilline???acide clavulanique dans un CHU de la r??gion parisienne, La Revue de M??decine Interne, vol.29, issue.3, pp.195-204, 2008.
DOI : 10.1016/j.revmed.2007.11.011

S. Mechkour, A. Vinat, M. Yilmaz, K. Faure, and B. Grandbastien, Qualit?? des prescriptions antibiotiques (fluoroquinolones, aminosides et amoxicilline-acide clavulanique)??; ??valuation dans les secteurs de m??decine d???un centre hospitalier universitaire, Pathologie Biologie, vol.59, issue.1, pp.9-15, 2011.
DOI : 10.1016/j.patbio.2010.07.017

S. Alfandari, I. Baudlot, M. Caillaux, E. Senneville, L. Thirard et al., ??valuation du??respect des??choix de??mol??cules recommand??es par??le??guide d'antibioth??rapie de??l'adulte du??centre hospitalier de??Tourcoing, Pathologie Biologie, vol.55, issue.10, pp.486-495, 2007.
DOI : 10.1016/j.patbio.2007.08.006

F. Moreau, Réévaluation de l'antibiothérapie à 48-72h : étude prospective au CHRU de Lille, Lille, vol.2, 2012.

F. Jehl and D. Levêque, Perfusion continue des b??talactamines??: int??r??ts, inconv??nients, modalit??s pratiques, R??animation, vol.18, issue.4, 2009.
DOI : 10.1016/j.reaurg.2009.03.009

B. Davies, P. Coates, J. Clarke, A. Thawley, and J. Sutton, Bioavailability and pharmacokinetics of clavulanic acid in healthy subjects, Int J Clin Pharmacol. Feb, vol.23, issue.2, pp.70-73, 1985.

A. Arancibia, J. Guttmann, G. González, and C. González, Absorption and disposition kinetics of amoxicillin in normal human subjects., Antimicrobial Agents and Chemotherapy, vol.17, issue.2, pp.199-202, 1980.
DOI : 10.1128/AAC.17.2.199

G. Jamtvedt, J. Young, D. Kristoffersen, O. Brien, M. Oxman et al., Does telling people what they have been doing change what they do? A systematic review of the effects of audit and feedback. Qual Saf Health Care, pp.433-439, 2006.

P. Davey, E. Brown, E. Charani, L. Fenelon, I. Gould et al., Interventions to improve antibiotic prescribing practices for hospital inpatients, Cochrane Database Syst Rev, issue.4, p.3543, 2013.
DOI : 10.1002/14651858.cd003543

P. Mol, J. Wieringa, P. Nannanpanday, R. Gans, J. Degener et al., Improving compliance with hospital antibiotic guidelines: a time-series intervention analysis, Journal of Antimicrobial Chemotherapy, vol.55, issue.4, pp.550-557, 2005.
DOI : 10.1093/jac/dki037

URL : http://jac.oxfordjournals.org/cgi/content/short/55/4/550

A. Van-zanten, P. Engelfriet, K. Van-dillen, M. Van-veen, M. Nuijten et al., Importance of nondrug costs of intravenous antibiotic therapy, Critical Care, vol.7, issue.6, pp.184-90, 2003.
DOI : 10.1186/cc2388

E. Sellier, P. Pavese, S. Gennai, J. Stahl, J. Labarère et al., Factors and outcomes associated with physicians' adherence to recommendations of infectious disease consultations for inpatients, Journal of Antimicrobial Chemotherapy, vol.65, issue.1, pp.156-62, 2010.
DOI : 10.1093/jac/dkp406

URL : https://hal.archives-ouvertes.fr/hal-00453687

A. White, R. Atmar, J. Wilson, T. Cate, C. Stager et al., Effects of Requiring prior Authorization for Selected Antimicrobials: Expenditures, Susceptibilities, and Clinical Outcomes, Clinical Infectious Diseases, vol.25, issue.2, pp.230-239, 1997.
DOI : 10.1086/514545